FONAR Corporation (FONR)
USD 13.49
(-2.25%)
USD 13.49
(-2.25%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 57.45 Million USD | 15.48% |
| 2023 | 49.75 Million USD | -6.31% |
| 2022 | 53.1 Million USD | -1.9% |
| 2021 | 54.13 Million USD | 0.22% |
| 2020 | 54.01 Million USD | 249.67% |
| 2019 | 15.44 Million USD | -3.91% |
| 2018 | 16.07 Million USD | 1.41% |
| 2017 | 15.85 Million USD | -34.25% |
| 2016 | 24.11 Million USD | -6.21% |
| 2015 | 25.7 Million USD | -16.76% |
| 2014 | 30.88 Million USD | -12.64% |
| 2013 | 35.35 Million USD | 56.88% |
| 2012 | 22.53 Million USD | -12.37% |
| 2011 | 25.71 Million USD | -6.17% |
| 2010 | 27.4 Million USD | -12.27% |
| 2009 | 31.23 Million USD | -20.53% |
| 2008 | 39.3 Million USD | 23.67% |
| 2007 | 31.78 Million USD | 21.7% |
| 2006 | 26.11 Million USD | 10.17% |
| 2005 | 23.7 Million USD | -29.59% |
| 2004 | 33.66 Million USD | 29.36% |
| 2003 | 26.02 Million USD | -29.4% |
| 2002 | 36.86 Million USD | -14.62% |
| 2001 | 43.17 Million USD | 29.67% |
| 2000 | 33.29 Million USD | -13.07% |
| 1999 | 38.3 Million USD | 7.28% |
| 1998 | 35.7 Million USD | 7.21% |
| 1997 | 33.3 Million USD | 123.49% |
| 1996 | 14.9 Million USD | -1.97% |
| 1995 | 15.2 Million USD | -22.05% |
| 1994 | 19.5 Million USD | -21.37% |
| 1993 | 24.8 Million USD | -9.82% |
| 1992 | 27.5 Million USD | -9.54% |
| 1991 | 30.4 Million USD | -14.85% |
| 1990 | 35.7 Million USD | -21.88% |
| 1989 | 45.7 Million USD | 44.16% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 52.6 Million USD | 14.44% |
| 2024 Q2 | 45.96 Million USD | -3.2% |
| 2024 Q1 | 47.48 Million USD | -4.57% |
| 2024 Q4 | 57.45 Million USD | 9.23% |
| 2023 Q4 | 49.75 Million USD | 2.13% |
| 2023 FY | 49.75 Million USD | -6.31% |
| 2023 Q1 | 50.89 Million USD | -4.17% |
| 2023 Q2 | 49.42 Million USD | -2.88% |
| 2023 Q3 | 48.71 Million USD | -1.43% |
| 2022 Q4 | 53.1 Million USD | 3.37% |
| 2022 Q1 | 48.75 Million USD | -9.94% |
| 2022 Q2 | 51.28 Million USD | 5.19% |
| 2022 Q3 | 51.37 Million USD | 0.17% |
| 2022 FY | 53.1 Million USD | -1.9% |
| 2021 Q4 | 54.13 Million USD | 7.29% |
| 2021 Q3 | 50.45 Million USD | 0.37% |
| 2021 Q2 | 50.27 Million USD | -5.51% |
| 2021 Q1 | 53.2 Million USD | -1.51% |
| 2021 FY | 54.13 Million USD | 0.22% |
| 2020 Q2 | 46.59 Million USD | 5.83% |
| 2020 Q3 | 45.59 Million USD | -2.15% |
| 2020 Q4 | 54.01 Million USD | 18.48% |
| 2020 Q1 | 44.02 Million USD | 184.99% |
| 2020 FY | 54.01 Million USD | 249.67% |
| 2019 Q4 | 15.44 Million USD | 22.11% |
| 2019 FY | 15.44 Million USD | -3.91% |
| 2019 Q1 | 13.29 Million USD | -17.28% |
| 2019 Q2 | 13.01 Million USD | -2.17% |
| 2019 Q3 | 12.65 Million USD | -2.76% |
| 2018 Q1 | 15.44 Million USD | -2.55% |
| 2018 Q4 | 16.07 Million USD | 15.34% |
| 2018 Q3 | 13.93 Million USD | -8.23% |
| 2018 Q2 | 15.18 Million USD | -1.68% |
| 2018 FY | 16.07 Million USD | 1.41% |
| 2017 Q1 | 20.45 Million USD | -15.17% |
| 2017 Q2 | 19.27 Million USD | -5.75% |
| 2017 FY | 15.85 Million USD | -34.25% |
| 2017 Q4 | 15.85 Million USD | -3.33% |
| 2017 Q3 | 16.39 Million USD | -14.93% |
| 2016 FY | 24.11 Million USD | -6.21% |
| 2016 Q1 | 26.03 Million USD | 1.25% |
| 2016 Q4 | 24.11 Million USD | 0.84% |
| 2016 Q2 | 24.77 Million USD | -4.81% |
| 2016 Q3 | 23.91 Million USD | -3.5% |
| 2015 FY | 25.7 Million USD | -16.76% |
| 2015 Q2 | 28.82 Million USD | -6.01% |
| 2015 Q3 | 27.54 Million USD | -4.42% |
| 2015 Q1 | 30.66 Million USD | -0.71% |
| 2015 Q4 | 25.7 Million USD | -6.67% |
| 2014 FY | 30.88 Million USD | -12.64% |
| 2014 Q4 | 30.88 Million USD | -5.6% |
| 2014 Q2 | 35.02 Million USD | -0.89% |
| 2014 Q1 | 35.34 Million USD | -0.03% |
| 2014 Q3 | 32.71 Million USD | -6.6% |
| 2013 Q2 | 22.66 Million USD | -0.81% |
| 2013 Q3 | 38.3 Million USD | 69.02% |
| 2013 Q4 | 35.35 Million USD | -7.71% |
| 2013 FY | 35.35 Million USD | 56.88% |
| 2013 Q1 | 22.84 Million USD | 1.39% |
| 2012 Q1 | 25.65 Million USD | -0.25% |
| 2012 Q2 | 24.27 Million USD | -5.37% |
| 2012 Q3 | 24.16 Million USD | -0.43% |
| 2012 Q4 | 22.53 Million USD | -6.77% |
| 2012 FY | 22.53 Million USD | -12.37% |
| 2011 FY | 25.71 Million USD | -6.17% |
| 2011 Q4 | 25.71 Million USD | -5.23% |
| 2011 Q3 | 27.13 Million USD | -1.8% |
| 2011 Q2 | 27.63 Million USD | 1.64% |
| 2011 Q1 | 27.18 Million USD | -0.8% |
| 2010 Q4 | 27.4 Million USD | -5.59% |
| 2010 Q3 | 29.02 Million USD | -5.69% |
| 2010 Q2 | 30.77 Million USD | -3.95% |
| 2010 Q1 | 32.04 Million USD | 2.59% |
| 2010 FY | 27.4 Million USD | -12.27% |
| 2009 Q1 | 37.97 Million USD | -3.39% |
| 2009 Q4 | 31.23 Million USD | -4.13% |
| 2009 FY | 31.23 Million USD | -20.53% |
| 2009 Q2 | 36.6 Million USD | -3.59% |
| 2009 Q3 | 32.58 Million USD | -11.0% |
| 2008 Q2 | 35.89 Million USD | 8.07% |
| 2008 Q1 | 33.21 Million USD | 4.51% |
| 2008 Q3 | 38.28 Million USD | 6.68% |
| 2008 Q4 | 39.3 Million USD | 2.65% |
| 2008 FY | 39.3 Million USD | 23.67% |
| 2007 Q3 | 30.51 Million USD | 2.44% |
| 2007 Q2 | 29.78 Million USD | 17.97% |
| 2007 Q1 | 25.24 Million USD | -3.32% |
| 2007 Q4 | 31.78 Million USD | 4.15% |
| 2007 FY | 31.78 Million USD | 21.7% |
| 2006 Q3 | 23.18 Million USD | -3.9% |
| 2006 Q4 | 26.11 Million USD | 12.62% |
| 2006 FY | 26.11 Million USD | 10.17% |
| 2006 Q1 | 21.77 Million USD | -8.13% |
| 2006 Q2 | 24.12 Million USD | 10.81% |
| 2005 Q3 | 23.05 Million USD | -23.58% |
| 2005 FY | 23.7 Million USD | -29.59% |
| 2005 Q4 | 23.7 Million USD | 2.83% |
| 2005 Q2 | 30.16 Million USD | -7.74% |
| 2005 Q1 | 32.69 Million USD | -2.89% |
| 2004 Q4 | 33.66 Million USD | -0.11% |
| 2004 FY | 33.66 Million USD | 29.36% |
| 2004 Q1 | 25.87 Million USD | -0.57% |
| 2004 Q2 | 26.29 Million USD | 1.6% |
| 2004 Q3 | 33.7 Million USD | 28.19% |
| 2003 FY | 26.02 Million USD | -29.4% |
| 2003 Q4 | 26.02 Million USD | -22.53% |
| 2003 Q1 | 35.71 Million USD | -3.13% |
| 2003 Q2 | 33.5 Million USD | -6.17% |
| 2003 Q3 | 33.59 Million USD | 0.25% |
| 2002 Q1 | 39.69 Million USD | -8.06% |
| 2002 Q2 | 38.38 Million USD | -3.29% |
| 2002 Q4 | 36.86 Million USD | 3.49% |
| 2002 Q3 | 35.61 Million USD | -7.21% |
| 2002 FY | 36.86 Million USD | -14.62% |
| 2001 Q3 | 36.56 Million USD | -11.85% |
| 2001 Q4 | 43.17 Million USD | 18.08% |
| 2001 FY | 43.17 Million USD | 29.67% |
| 2001 Q2 | 41.47 Million USD | -4.3% |
| 2001 Q1 | 43.33 Million USD | 30.18% |
| 2000 FY | 33.29 Million USD | -13.07% |
| 2000 Q4 | 33.29 Million USD | 0.56% |
| 2000 Q3 | 33.1 Million USD | -2.91% |
| 2000 Q2 | 34.1 Million USD | -6.06% |
| 2000 Q1 | 36.3 Million USD | -5.22% |
| 1999 Q3 | 38.4 Million USD | -3.76% |
| 1999 Q1 | 42.5 Million USD | 19.05% |
| 1999 FY | 38.3 Million USD | 7.28% |
| 1999 Q4 | 38.3 Million USD | -0.26% |
| 1999 Q2 | 39.9 Million USD | -6.12% |
| 1998 Q4 | 35.7 Million USD | -0.56% |
| 1998 FY | 35.7 Million USD | 7.21% |
| 1998 Q1 | 32.8 Million USD | -1.5% |
| 1998 Q2 | 29.7 Million USD | -9.45% |
| 1998 Q3 | 35.9 Million USD | 20.88% |
| 1997 Q2 | 13.6 Million USD | -5.56% |
| 1997 Q4 | 33.3 Million USD | 139.57% |
| 1997 Q1 | 14.4 Million USD | -3.36% |
| 1997 Q3 | 13.9 Million USD | 2.21% |
| 1997 FY | 33.3 Million USD | 123.49% |
| 1996 Q1 | 14.2 Million USD | -6.58% |
| 1996 FY | 14.9 Million USD | -1.97% |
| 1996 Q4 | 14.9 Million USD | 2.76% |
| 1996 Q3 | 14.5 Million USD | 5.84% |
| 1996 Q2 | 13.7 Million USD | -3.52% |
| 1995 Q2 | 16.2 Million USD | -11.96% |
| 1995 Q1 | 18.4 Million USD | -5.64% |
| 1995 Q3 | 16.5 Million USD | 1.85% |
| 1995 Q4 | 15.2 Million USD | -7.88% |
| 1995 FY | 15.2 Million USD | -22.05% |
| 1994 Q4 | 19.5 Million USD | -7.14% |
| 1994 FY | 19.5 Million USD | -21.37% |
| 1994 Q3 | 21 Million USD | 0.96% |
| 1994 Q1 | 23.5 Million USD | -5.24% |
| 1994 Q2 | 20.8 Million USD | -11.49% |
| 1993 Q1 | 25.7 Million USD | -6.55% |
| 1993 Q2 | 25.1 Million USD | -2.33% |
| 1993 Q3 | 26.2 Million USD | 4.38% |
| 1993 Q4 | 24.8 Million USD | -5.34% |
| 1993 FY | 24.8 Million USD | -9.82% |
| 1992 Q3 | 27.3 Million USD | -1.09% |
| 1992 FY | 27.5 Million USD | -9.54% |
| 1992 Q1 | 28.8 Million USD | -5.26% |
| 1992 Q2 | 27.6 Million USD | -4.17% |
| 1992 Q4 | 27.5 Million USD | 0.73% |
| 1991 Q1 | 34.3 Million USD | -3.92% |
| 1991 Q4 | 30.4 Million USD | -4.4% |
| 1991 Q2 | 34.7 Million USD | 1.17% |
| 1991 FY | 30.4 Million USD | -14.85% |
| 1991 Q3 | 31.8 Million USD | -8.36% |
| 1990 Q4 | 35.7 Million USD | -2.72% |
| 1990 Q3 | 36.7 Million USD | -5.66% |
| 1990 FY | 35.7 Million USD | -21.88% |
| 1990 Q2 | 38.9 Million USD | 0.0% |
| 1989 FY | 45.7 Million USD | 44.16% |
| 1989 Q4 | 45.7 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 51.25 Million USD | -12.104% |
| BrainsWay Ltd. | 15.31 Million USD | -275.196% |
| Cerus Corporation | 144.3 Million USD | 60.183% |
| Envoy Medical, Inc. | 9.4 Million USD | -511.121% |
| electroCore, Inc. | 8.94 Million USD | -542.343% |
| Helius Medical Technologies, Inc. | 5.34 Million USD | -975.582% |
| IceCure Medical Ltd | 4.24 Million USD | -1252.898% |
| Inogen, Inc. | 121.38 Million USD | 52.664% |
| OrthoPediatrics Corp. | 72.56 Million USD | 20.815% |
| Lucid Diagnostics Inc. | 29.58 Million USD | -94.238% |
| Monogram Orthopaedics, Inc. | 3.18 Million USD | -1705.739% |
| MaxCyte, Inc. | 36.1 Million USD | -59.131% |
| NeuroOne Medical Technologies Corporation | 1.84 Million USD | -3009.328% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -13410.498% |
| Orthofix Medical Inc. | 326.58 Million USD | 82.407% |
| PAVmed Inc | 57.13 Million USD | -0.561% |
| Rapid Micro Biosystems, Inc. | 25.46 Million USD | -125.651% |
| RxSight, Inc. | 22.18 Million USD | -158.958% |
| Sight Sciences, Inc. | 46.43 Million USD | -23.735% |
| SI-BONE, Inc. | 61.05 Million USD | 5.884% |
| TELA Bio, Inc. | 59.16 Million USD | 2.889% |
| Treace Medical Concepts, Inc. | 113.96 Million USD | 49.585% |
| Vivos Therapeutics, Inc. | 10.31 Million USD | -456.813% |
| Acutus Medical, Inc. | 54.83 Million USD | -4.775% |
| Talis Biomedical Corporation | 29.22 Million USD | -96.611% |
| Spectral AI, Inc. | 12.4 Million USD | -363.33% |
| Nano-X Imaging Ltd. | 23.13 Million USD | -148.369% |
| CVRx, Inc. | 39.28 Million USD | -46.269% |
| DIH Holding US, Inc. Warrants | 11.95 Million USD | -380.492% |
| PetVivo Holdings, Inc. | 2.42 Million USD | -2265.191% |
| Bioventus Inc. | 589.79 Million USD | 90.258% |
| Venus Concept Inc. | 107.1 Million USD | 46.353% |
| TriSalus Life Sciences, Inc. | 51.66 Million USD | -11.216% |
| LivaNova PLC | 1.15 Billion USD | 95.012% |
| 908 Devices Inc. | 37.49 Million USD | -53.261% |
| Alphatec Holdings, Inc. | 703.48 Million USD | 91.832% |
| Nemaura Medical Inc. | 26.37 Million USD | -117.829% |
| NeuroPace, Inc. | 86.99 Million USD | 33.955% |
| LENSAR, Inc. | 22.4 Million USD | -156.404% |
| Apyx Medical Corporation | 52.31 Million USD | -9.824% |
| Cutera, Inc. | 518.12 Million USD | 88.91% |
| STRATA Skin Sciences, Inc. | 29.32 Million USD | -95.914% |
| BioSig Technologies, Inc. | 4.68 Million USD | -1126.416% |
| Anika Therapeutics, Inc. | 58.36 Million USD | 1.558% |
| ClearPoint Neuro, Inc. | 21.48 Million USD | -167.394% |
| Integra LifeSciences Holdings Corporation | 2.19 Billion USD | 97.381% |
| Axonics, Inc. | 82.35 Million USD | 30.235% |
| Outset Medical, Inc. | 190.91 Million USD | 69.904% |
| IRIDEX Corporation | 24.91 Million USD | -130.624% |
| PROCEPT BioRobotics Corporation | 123.96 Million USD | 53.65% |
| IRadimed Corporation | 20.73 Million USD | -177.092% |
| Tivic Health Systems, Inc. | 1.67 Million USD | -3332.352% |
| INVO Bioscience, Inc. | 19.99 Million USD | -187.36% |
| Telesis Bio, Inc. | 40.87 Million USD | -40.576% |
| Viemed Healthcare, Inc. | 40.79 Million USD | -40.861% |
| Varex Imaging Corporation | 668.6 Million USD | 91.406% |
| Quipt Home Medical Corp. | 136.29 Million USD | 57.843% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -1508.555% |
| Pulmonx Corporation | 60.63 Million USD | 5.242% |
| Dynatronics Corporation | 11.78 Million USD | -387.751% |
| Modular Medical, Inc. | 2.27 Million USD | -2428.943% |
| ReShape Lifesciences Inc. | 4.06 Million USD | -1313.818% |
| Semler Scientific, Inc. | 6.27 Million USD | -816.389% |
| InMode Ltd. | 75.91 Million USD | 24.312% |
| Bruker Corporation | 2.83 Billion USD | 97.974% |
| Cytosorbents Corporation | 29.98 Million USD | -91.618% |
| DexCom, Inc. | 4.19 Billion USD | 98.631% |
| Align Technology, Inc. | 2.45 Billion USD | 97.658% |
| Viveve Medical, Inc. | 10.84 Million USD | -429.709% |
| ZimVie Inc. | 795.85 Million USD | 92.78% |
| Movano Inc. | 5.97 Million USD | -862.116% |
| Cytek Biosciences, Inc. | 104.6 Million USD | 45.072% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -13410.498% |
| DIH Holdings US, Inc. Class A Common Stock | 11.95 Million USD | -380.492% |
| Tandem Diabetes Care, Inc. | 639.02 Million USD | 91.009% |
| Profound Medical Corp. | 12.66 Million USD | -353.641% |
| Insulet Corporation | 1.85 Billion USD | 96.903% |
| enVVeno Medical Corporation | 2.43 Million USD | -2259.654% |
| Surmodics, Inc. | 65.82 Million USD | 12.709% |
| iCAD, Inc. | 8 Million USD | -618.13% |
| Nuwellis, Inc. | 6.78 Million USD | -747.457% |
| Biotricity, Inc. | 35.91 Million USD | -59.962% |
| iRhythm Technologies, Inc. | 223.04 Million USD | 74.24% |
| Aethlon Medical, Inc. | 2.47 Million USD | -2217.165% |
| InspireMD, Inc. | 8.14 Million USD | -605.694% |
| PAVmed Inc. | 57.13 Million USD | -0.561% |
| BIOLASE, Inc. | 35.34 Million USD | -62.548% |
| Beyond Air, Inc. | 29.77 Million USD | -92.973% |
| AxoGen, Inc. | 101.16 Million USD | 43.202% |
| Vivani Medical, Inc. | 25.03 Million USD | -129.5% |
| Tactile Systems Technology, Inc. | 87.79 Million USD | 34.556% |
| Inari Medical, Inc. | 209.32 Million USD | 72.551% |
| UFP Technologies, Inc. | 118.04 Million USD | 51.326% |
| QT Imaging Holdings, Inc. | 12.69 Million USD | -352.761% |
| Heart Test Laboratories, Inc. | 2.18 Million USD | -2528.661% |
| Tenon Medical, Inc. | 5.56 Million USD | -932.11% |
| Autonomix Medical, Inc. Common Stock | 1.77 Million USD | -3129.768% |
| Co-Diagnostics, Inc. | 17.63 Million USD | -225.832% |
| AdaptHealth Corp. | 3.15 Billion USD | 98.178% |
| Sintx Technologies, Inc. | 6.59 Million USD | -771.494% |
| NanoVibronix, Inc. | 2.68 Million USD | -2039.15% |
| Quanterix Corporation | 78.08 Million USD | 26.416% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -1508.555% |
| Sensus Healthcare, Inc. | 4.88 Million USD | -1076.204% |
| Pacific Biosciences of California, Inc. | 1.04 Billion USD | 94.5% |
| TransMedics Group, Inc. | 568.84 Million USD | 89.899% |
| ReWalk Robotics Ltd. | 16.68 Million USD | -244.429% |
| NeuroMetrix, Inc. | 1.33 Million USD | -4209.995% |
| Hyperfine, Inc. | 9.8 Million USD | -486.302% |
| Establishment Labs Holdings Inc. | 250.24 Million USD | 77.04% |
| Biomerica, Inc. | 2.66 Million USD | -2057.626% |
| Bone Biologics Corporation | 831.4 Thousand USD | -6810.926% |
| AVITA Medical, Inc. | 19.86 Million USD | -189.234% |
| Bluejay Diagnostics, Inc. | 1.97 Million USD | -2811.186% |
| Silk Road Medical, Inc | 114.15 Million USD | 49.668% |